Figure 1.

CD204 is correlated with unfavorable overall survival in glioma. (A, B, C) High expression of CD204 predicted worse outcome in whole‐grade glioma patients in the CGGA microarray and RNA‐seq dataset and the TCGA RNA‐seq dataset. The samples were divided into a high‐ and low‐expression group based on the best cut‐off point of CD204 mRNA expression value. (D, E, F) High expression of CD204 predicted worse outcome in GBM in the CGGA microarray and RNA‐seq dataset and the TCGA RNA‐seq dataset